Game-changing impact™

Driving transformation through game-changing innovation

Aneurysm Therapy

A brain aneurysm is a weak, bulging spot on the wall of an artery. Our unique portfolio for ruptured and unruptured aneurysms is backed by numerous clinical studies and independent research for great performance and versatility.

Ischemic Stroke and Carotid Artery Disease

A stroke is a permanent injury to the brain caused by a blockage of blood flow that deprives brain tissue of oxygen and nutrients. This diverse portfolio includes carotid stents, aspiration catheters, and mechanical thrombectomy products.

Neurovascular Malformations

Malformations are an abnormal tangle of blood vessels that cause arteries to shunt directly into veins, the blood flow never slows down enough to provide oxygen and nutrients. We took a novel approach by designing a ready-to-use liquid embolic device for malformations.

Access Product Solutions

Terumo Neuro develops a full range of access products, including catheters and guidewires, that allow physicians to gain access to the treatment area. We strive to provide a wide range of innovative, high-quality access products designed to improve patient outcomes.

Products

Our cutting-edge products lead the way in neuroendovascular therapies.

Latest Videos

Dr. Kendrick Johnson Video Highlights the Importance of Stroke Awareness

World Stroke Day Patient Stories from Germany

Ischemic Stroke Patient Video

Latest News

View newsroom

Oct 29, 2024

Terumo Neuro and Tulane University School of Medicine’s Dr. Kendrick Johnson Release Educational Video Highlighting the Importance of Stroke Awareness and Equitable Healthcare in Honor of World Stroke Day 2024

In honor of World Stroke Day on October 29, 2024, Terumo Neuro has partnered with Tulane University School of Medicine and Dr. Kendrick Johnson, Assistant Professor of Neurosurgery at Tulane University School of Medicine, to release a compelling educational video focused on raising awareness about stroke education and the critical need for equitable healthcare access.

Sep 12, 2024

MicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.

Jul 23, 2024

MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms

MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms.

Upcoming Events

February 5-7, 2025 Los Angeles, CA

ISC 2025

International Stroke Conference